CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy

Failure to achieve pathologic complete response is associated with poor prognosis in breast cancer patients following neoadjuvant chemotherapy (NACT). However, prognostic biomarkers for clinical outcome are unclear in this patient population. Cyclin-dependent kinase 9 (CDK9) is often dysregulated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlafstein, Ashley J., Withers, Allison E., Rudra, Soumon, Danelia, Diana, Switchenko, Jeffrey M., Mister, Donna, Harari, Saul, Zhang, Hui, Daddacha, Waaqo, Ehdaivand, Shahrzad, Li, Xiaoxian, Torres, Mylin A., Yu, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204190/
https://www.ncbi.nlm.nih.gov/pubmed/30405916
http://dx.doi.org/10.1155/2018/6945129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204190/
https://www.ncbi.nlm.nih.gov/pubmed/30405916
http://dx.doi.org/10.1155/2018/6945129

Ejemplares similares